<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75AEC807-087D-48FC-A11C-9FD0D3DCB516"><gtr:id>75AEC807-087D-48FC-A11C-9FD0D3DCB516</gtr:id><gtr:name>Albert Ludwigs University of Freiburg</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Clinical Biochemist</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75AEC807-087D-48FC-A11C-9FD0D3DCB516"><gtr:id>75AEC807-087D-48FC-A11C-9FD0D3DCB516</gtr:id><gtr:name>Albert Ludwigs University of Freiburg</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F480A28A-1B19-4797-ADD7-A7E1D402AC46"><gtr:id>F480A28A-1B19-4797-ADD7-A7E1D402AC46</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:surname>Coll</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G108%2F617"><gtr:id>7ACC3166-CDB7-41B9-ACDC-1C12EB7B982C</gtr:id><gtr:title>Pro-opiomelanocortin-derived peptides and the control of energy balance and adrenal function.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G108/617</gtr:grantReference><gtr:abstractText>POMC is a large protein produced in the brain which is very important in controlling not only our appetite and how we expend energy but also in producing stress hormones from the adrenal glands. Children with genetic problems which mean they cannot make POMC properly become severely overweight and cannot mount a proper defence to even minor illnesses because of their lack of stress hormones. Although we know a lot about how POMC works, there are still many unanswered questions. We do not fully understand how POMC controls the adrenal gland nor which of the smaller parts which make up POMC are most important in signalling within the brain. These studies aim to clarify these areas of uncertainty and help us more fully understand the mechanisms which control appetite, energy expenditure and adrenal gland function. This could ultimately lead to better treatments for human disorders such as obesity and adrenal tumours.</gtr:abstractText><gtr:technicalSummary>Hypothalamic neurons expressing the neuroendocrine pro-peptide pro-opiomelanocortin (POMC) are critically involved in the integration of nutritional and hormonal signals and the regulation of both appetite and energy expenditure. Inactivating mutations of the POMC gene in humans and mice result in hyperphagia, obesity and glucocorticoid (GC) deficiency. However, a precise understanding of the molecular physiology of POMC is elusive as extensive post-translational processing yields a number of peptides with diverse physiological roles. I have recently studied energy balance and adrenal function in Pomc null mice generated in the sponsor?s laboratory. While this work has provided novel insights into POMC biology, there remain unanswered questions. Firstly, an understanding of the roles of -MSH in energy balance has been hampered by the concurrent GC deficiency inevitable with the loss of corticotroph activity encoded within ACTH. Second, although the N -terminal part of POMC is highly conserved across species, the true physiological roles of peptides contained within this fragment are still contentious. I have recently shown that the peripheral administration of synthetic 1-28 N-POMC can suppress food intake in wild type and Pomc-/- mice suggesting that this non-melanocortin peptide may have a previously unsuspected role in energy homeostasis. 
The principal questions addressed in the proposal are;
1)To what extent does glucocorticoid deficiency modulate the phenotype of POMC deficiency?
I will study the phenotype of Pomc-/- mice in the presence and absence of GC replacement.
2) Can the production of ACTH be dissociated from -MSH thereby allowing us to generate a murine model selectively lacking -MSH?
From what is known of the structural requirements for ACTH bioactivity, the cleavage sites within it required to generate -MSH could be disrupted without losing ACTH bioactivity. I aim to validate this hypothesis in vitro using synthetic peptides and cloned MC2R a use an identical strategy to generate a murine model deficient in - MSH generation without loss of corticotroph activity.
3) What is the physiological function of N-terminal peptides encoded in POMC?
 I will administer synthetic peptides to established mouse lines and generate a murine model in which the production of N-terminal peptides is disrupted.
This project will build on the knowledge of melanocortin biology already acquired using murine genetics. I aim to further delineate the physiological roles of constituent fragments of POMC. I will acquire state of the art expertise in murine gene targeting through working in the laboratory of Dr Allan Bradley at the Sanger.
(400)</gtr:technicalSummary><gtr:fund><gtr:end>2009-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>590881</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Albert Ludwigs University of Freiburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Felix Beuschlein</gtr:description><gtr:id>7A5FEC9A-DC31-4578-928C-CDE1AE1A0B94</gtr:id><gtr:impact>publiction 16899584</gtr:impact><gtr:outcomeId>B0352821829-1</gtr:outcomeId><gtr:partnerContribution>combned analysis of adrenal tissue, reagent exchange</gtr:partnerContribution><gtr:piContribution>ideas and reagents exchanged, analysis of tissue</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Rouen meeeting, 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5FA24285-7346-4023-9A16-4FCDD41BE28E</gtr:id><gtr:impact>Title: No amelioration of the metabolic phenotype of POMC deficiency with additional AgRP deficiency 
Authors: Corander MP, Rimmington D, Challis BG, O'Rahilly S and Coll AP 

The 7th International Congress of Neuroendocrinology, July 2010, Rouen, France


gave dr corander good experience in networking at international meeting</gtr:impact><gtr:outcomeId>QJap5RtscGQ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>utrecht meeting 2010</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1786FE29-729F-40BF-B158-1CD9F57D095E</gtr:id><gtr:impact>Title: No amelioration of the metabolic phenotype of POMC deficiency with additional AgRP deficiency 
Authors: Corander MP, Rimmington D, Challis BG, O'Rahilly S and Coll AP 
Presented at: The 6th International Melanocortin Meeting, July 2010, Utrecht, The Netherlands 



raised profile of our work</gtr:impact><gtr:outcomeId>m6Dsb3wyyP2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge science Festival</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0053CDA4-9E6B-46AE-B90B-B5CCBEC01175</gtr:id><gtr:impact>data used to highlight the growing problems of obesity and related disorders

no immediate notable impact but part of the broader sweep to show the utility of murine models</gtr:impact><gtr:outcomeId>093E0A139DF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Abcam meeting, Fitzwilliam ,Cambridge 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1334B61B-6EF5-4B6E-9A7D-4E058855DC65</gtr:id><gtr:impact>&amp;quot;Melanocortins and beyond 
- the hypothalamic control of energy balance&amp;quot; AP Coll

Programming Obesity: 
Central and Peripheral Contributors 
 
 April 14-16, 2013 
Fitzwilliam College, University of Cambridge


useful post presentation discussion with peers on how to take evolving data forward</gtr:impact><gtr:outcomeId>DKZPNeLczwx</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>HEFCE Clinical Senior Lecturer Award</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Higher Education Funding Council for England (HEFCE)</gtr:fundingOrg><gtr:id>8B8E9E2D-B174-452F-B01A-F95C684EDC53</gtr:id><gtr:outcomeId>11007444F170</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>178328</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Project Grant (The role of Agouti-related peptide (AgRP) in the control of energy homeostasis)</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>5F82BCA7-7C26-444D-A494-FE025655ED22</gtr:id><gtr:outcomeId>5C0695106680</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2185000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>32654353-E884-4352-BFF7-12CD723796DF</gtr:id><gtr:outcomeId>87C2E29E5E80</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A9508477-1CD1-4CDC-9A52-9E4644882BF1</gtr:id><gtr:title>The hormonal control of food intake.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed3a95f09732ed446c490ae181b3db35"><gtr:id>ed3a95f09732ed446c490ae181b3db35</gtr:id><gtr:otherNames>Coll AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>86B1799A85C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81BF1592-63C6-43FD-9039-052B68D36924</gtr:id><gtr:title>Is leptin an important physiological regulator of CRP?</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a6d40f6e987ca561a860bb1c9620ba0"><gtr:id>3a6d40f6e987ca561a860bb1c9620ba0</gtr:id><gtr:otherNames>Hutchinson WL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>C793A4822CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C6142F5-BA1D-4308-93FA-7400036153F8</gtr:id><gtr:title>Peripheral mechanisms contributing to the glucocorticoid hypersensitivity in proopiomelanocortin null mice treated with corticosterone.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cce0e28d158892aca9f1962648cd7b0a"><gtr:id>cce0e28d158892aca9f1962648cd7b0a</gtr:id><gtr:otherNames>Michailidou Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>575F32A4A45</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B73D6D61-9682-48A4-A2D4-193E00E43600</gtr:id><gtr:title>Pro-opiomelanocortin modulates the thermogenic and physical activity responses to high-fat feeding and markedly influences dietary fat preference.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4f003e51f49a2c7189a7a2037fe9d60"><gtr:id>f4f003e51f49a2c7189a7a2037fe9d60</gtr:id><gtr:otherNames>Tung YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>87A09D457B4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF5C9001-2315-4911-9AF8-2CD34F5927E6</gtr:id><gtr:title>Proopiomelanocortin-deficient mice are hypersensitive to the adverse metabolic effects of glucocorticoids.</gtr:title><gtr:parentPublicationTitle>Diabetes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed3a95f09732ed446c490ae181b3db35"><gtr:id>ed3a95f09732ed446c490ae181b3db35</gtr:id><gtr:otherNames>Coll AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0012-1797</gtr:issn><gtr:outcomeId>585d4f486d7f41.94270742</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDF3E7FD-8E92-4CE9-98C6-C217E5155893</gtr:id><gtr:title>&amp;quot;Are melanocortin receptors constitutively active in vivo?&amp;quot;.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed3a95f09732ed446c490ae181b3db35"><gtr:id>ed3a95f09732ed446c490ae181b3db35</gtr:id><gtr:otherNames>Coll AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>pm_12669_29_23872416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8B72BF0-660E-4C5A-B826-F261AC8AABB9</gtr:id><gtr:title>Leptin regulates peripheral lipid metabolism primarily through central effects on food intake.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9144d286283a2b002ae415a1fca26cfb"><gtr:id>9144d286283a2b002ae415a1fca26cfb</gtr:id><gtr:otherNames>Prieur X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>18893D6E50E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F8B6A4F-C449-4F8C-BCDF-41A5AE244FF1</gtr:id><gtr:title>Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed3a95f09732ed446c490ae181b3db35"><gtr:id>ed3a95f09732ed446c490ae181b3db35</gtr:id><gtr:otherNames>Coll AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>5CD86A78351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C322317-07C2-4FD5-B5C1-57CAA04BB511</gtr:id><gtr:title>SnapShot: the hormonal control of food intake.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed3a95f09732ed446c490ae181b3db35"><gtr:id>ed3a95f09732ed446c490ae181b3db35</gtr:id><gtr:otherNames>Coll AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>YTeiD5XJch6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>828B724C-D650-46B6-AAA0-28715D26AB89</gtr:id><gtr:title>Science of self-preservation: how melanocortin action in the brain modulates body weight, blood pressure, and ischemic damage.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a29601a645e1aaed50e8d97e7ec77516"><gtr:id>a29601a645e1aaed50e8d97e7ec77516</gtr:id><gtr:otherNames>Corander MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>F891F659746</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B616F95A-B5E3-44A9-94EE-58FDF97151CC</gtr:id><gtr:title>Loss of agouti-related peptide does not significantly impact the phenotype of murine POMC deficiency.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a29601a645e1aaed50e8d97e7ec77516"><gtr:id>a29601a645e1aaed50e8d97e7ec77516</gtr:id><gtr:otherNames>Corander MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>pm_12669_29_21363936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2CF3921-62B6-4C5C-B95D-743D5C401ACD</gtr:id><gtr:title>The effects of neurokinin B upon gonadotrophin release in male rodents.</gtr:title><gtr:parentPublicationTitle>Journal of neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a29601a645e1aaed50e8d97e7ec77516"><gtr:id>a29601a645e1aaed50e8d97e7ec77516</gtr:id><gtr:otherNames>Corander MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0953-8194</gtr:issn><gtr:outcomeId>pm_12669_29_20041982</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>548A3D1C-9206-4CE0-93B2-540FBC2F2AA1</gtr:id><gtr:title>Effects of pro-opiomelanocortin (POMC) on food intake and body weight: mechanisms and therapeutic potential?</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed3a95f09732ed446c490ae181b3db35"><gtr:id>ed3a95f09732ed446c490ae181b3db35</gtr:id><gtr:otherNames>Coll AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>8388DD706CA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6A7B7BD-8D40-48B4-B46B-7D96D363FAC2</gtr:id><gtr:title>A comparative study of the central effects of specific proopiomelancortin (POMC)-derived melanocortin peptides on food intake and body weight in pomc null mice.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4f003e51f49a2c7189a7a2037fe9d60"><gtr:id>f4f003e51f49a2c7189a7a2037fe9d60</gtr:id><gtr:otherNames>Tung YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>49A4AA90D75</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>418C1D5F-E410-4250-B664-9ADDDC927926</gtr:id><gtr:title>The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3cb5c6937897be2fe4df3f6a8fd8fadd"><gtr:id>3cb5c6937897be2fe4df3f6a8fd8fadd</gtr:id><gtr:otherNames>Gerken T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>65E1CBC9862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C551F8AC-7472-4DB4-8253-C36B0F90E3FF</gtr:id><gtr:title>Orexin expression is regulated by alpha-melanocyte-stimulating hormone.</gtr:title><gtr:parentPublicationTitle>Journal of neuroendocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85f23686da9e1d85aec9daafee5fc2d2"><gtr:id>85f23686da9e1d85aec9daafee5fc2d2</gtr:id><gtr:otherNames>L?pez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0953-8194</gtr:issn><gtr:outcomeId>02221B9894F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FF58BDA-F799-4FBE-8EAE-D7B8B9D1DFB3</gtr:id><gtr:title>Novel leptin-regulated genes revealed by transcriptional profiling of the hypothalamic paraventricular nucleus.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f4f003e51f49a2c7189a7a2037fe9d60"><gtr:id>f4f003e51f49a2c7189a7a2037fe9d60</gtr:id><gtr:otherNames>Tung YC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>ECA61F951C3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50888394-8128-4235-BC73-D56C75A1B0F1</gtr:id><gtr:title>Melanocortins and body weight regulation: glucocorticoids, Agouti-related protein and beyond.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a29601a645e1aaed50e8d97e7ec77516"><gtr:id>a29601a645e1aaed50e8d97e7ec77516</gtr:id><gtr:otherNames>Corander MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>pm_12669_29_21199644</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A0260DD-F438-4336-A823-1AD33FBB7FD8</gtr:id><gtr:title>Desacetyl-a-melanocyte stimulating hormone and a-melanocyte stimulating hormone are required to regulate energy balance.</gtr:title><gtr:parentPublicationTitle>Molecular metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e10ab4dae7172d6cbc33f542d1e260c"><gtr:id>7e10ab4dae7172d6cbc33f542d1e260c</gtr:id><gtr:otherNames>Mountjoy KG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2212-8778</gtr:issn><gtr:outcomeId>5a616a093e9d65.68922612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ED8E9EE-4300-4EF4-B8A2-C60E650DB77C</gtr:id><gtr:title>Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.</gtr:title><gtr:parentPublicationTitle>Molecular endocrinology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff14a6b854beb267d5523684088eccca"><gtr:id>ff14a6b854beb267d5523684088eccca</gtr:id><gtr:otherNames>Sai S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0888-8809</gtr:issn><gtr:outcomeId>D8B2FC72E90</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G108/617</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>